All Stories

  1. Neuronal Dynamics of Menstrually Related Migraine
  2. Cycling sensitivity across migraine phases: A longitudinal case–control study
  3. Management of cluster headache: Treatments and their mechanisms
  4. Crossing the Rubicon? The future impact of artificial intelligence on headache medicine
  5. Other primary headaches: Distinct clinical features and uncertain pathophysiology
  6. Update in the understanding of new daily persistent headache
  7. Characterization of trigeminal C‐fiber reactivity through capsaicin‐induced release of calcitonin gene‐related peptide
  8. Sumatriptan prevents central sensitization specifically in the trigeminal dermatome in humans
  9. Galcanezumab modulates Capsaicin-induced C-fiber reactivity
  10. A Review of Current Perspectives on Facial Presentations of Primary Headaches
  11. Cycling multisensory changes in migraine: more than a headache
  12. Migraine monoclonal antibodies against CGRP change brain activity depending on ligand or receptor target – an fMRI study
  13. High-Density Electroencephalography-Informed Multiband Functional Magnetic Resonance Imaging Reveals Rhythm-Specific Activations Within the Trigeminal Nociceptive Network
  14. Trigeminal sensory modulatory effects of galcanezumab and clinical response prediction
  15. Noninvasive vagus nerve stimulation modulates trigeminal but not extracephalic somatosensory perception: functional evidence for a trigemino-vagal system in humans
  16. Orofacial pain disorders: An overview and diagnostic approach
  17. Update of New Daily Persistent Headache
  18. Aura in trigeminal autonomic cephalalgia is probably mediated by comorbid migraine with aura
  19. Trigemino-autonome Kopfschmerzen in der Praxis
  20. Association between COVID-19 and headache: What evidence and history tell us
  21. Cluster headache in Asian populations: Similarities, disparities, and a narrative review of the mechanisms of the chronic subtype
  22. New insight into the cranial nerve pathology secondary to elevated CSF pressure
  23. Redefining migraine phases – a suggestion based on clinical, physiological, and functional imaging evidence
  24. Headache highlights 2019: Junior editors’ choice
  25. Targeting migraine treatment with neuroimaging—Pharmacological neuroimaging in headaches
  26. We still have no data to change the diagnostic criteria for chronic migraine
  27. Current understanding of premonitory networks in migraine: A window to attack generation
  28. Risk factors and psychological impact of syncope in migraine patients
  29. Migraine understood as a sensory threshold disease
  30. Oral contraceptive use and its association with symptomatology in migraine patients
  31. Quantitative sensory testing in migraine patients must be phase-specific
  32. Galectin-3 and Its Genetic Variation rs4644 Modulate Enterovirus 71 Infection
  33. Association between migraine and risk of venous thromboembolism: A nationwide cohort study
  34. Migraine and incidence of ischemic stroke: A nationwide population-based study
  35. Increased risk of Bell palsy in patients with migraine: A nationwide cohort study
  36. Increased risk of urinary calculi in patients with migraine: A nationwide cohort study
  37. Epidemiology of Headache Disorders in the Asia-Pacific Region
  38. Comparisons of disability, quality of life, and resource use between chronic and episodic migraineurs: A clinic-based study in Taiwan
  39. High-pressure headaches: idiopathic intracranial hypertension and its mimics
  40. Migraine diagnosis: Screening items, instruments, and scales
  41. New daily persistent headache: Should migrainous features be incorporated?
  42. Fak56 functions downstream of integrin alphaPS3betanu and suppresses MAPK activation in neuromuscular junction growth